Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Biotricity Inc. is currently navigating 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. This portfolio is split between 2 distinct examiners, ensuring that the prosecution of each matter is handled independently. The involvement of 2 distinct art units further suggests that the company's medical device innovations may span different technical classifications, requiring a versatile approach to legal arguments. This distribution prevents any single examiner from having a disproportionate impact on the company's overall patent strategy. The intersection of clinical utility and mechanical reliability in this area often requires addressing both functional and structural claim elements.
The busiest examiner, HOLTZCLAW, MICHAEL T., is currently overseeing 1 pending office action. With a total of 2 pending office actions, this means the workload is evenly divided among the 2 distinct examiners involved. For practitioners, this 1 to 2 ratio of the busiest examiner's load to the total portfolio indicates a balanced administrative environment. Success in these 2 distinct art units will depend on tailoring responses to the specific technical requirements of each examiner, as each handles exactly 1 pending office action. This focused distribution allows for detailed attention to the specific issues raised in each case.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLTZCLAW, MICHAEL T. | 1 | 78.0% | +15.5% |
| HODGE, LAURA NICOLE | 1 | 49.2% | +40.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18274921 | MULTI-SENSOR WEARABLE PATCH | HODGE, LAURA NICOLE | 125d overdue |
| 19048220 | SMART PATCH FOR MONITORING HEALTH METRICS | HOLTZCLAW, MICHAEL T. | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18274921 | MULTI-SENSOR WEARABLE PATCH | HODGE, LAURA NICOLE | 125d overdue |
| 19048220 | SMART PATCH FOR MONITORING HEALTH METRICS | HOLTZCLAW, MICHAEL T. | — |
| Art Unit | Apps |
|---|---|
| 3796 | 1 |
| 3792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19048220 | SMART PATCH FOR MONITORING HEALTH METRICS | HOLTZCLAW, MICHAEL T. | 3796 | §103§112Other | Non-Final OA | — | Pending | Feb 07, 2025 |
| 18274921 | MULTI-SENSOR WEARABLE PATCH | HODGE, LAURA NICOLE | 3792 | §101§103 | Non-Final OA | 125d overdue | Pending | Jul 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBiotricity Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Michael T. Holtzclaw has the most, with 1 of Biotricity Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
